204
Participants
Start Date
April 15, 2022
Primary Completion Date
October 10, 2022
Study Completion Date
December 25, 2022
PA9159 nasal spray solution, 10 μg once daily for 14 days
PA9159 of 10 μg is delivered intranasally through a metered-dose mechanical spray pump, once daily in the morning for 14 days.
PA9159 nasal spray solution, 20 μg once daily for 14 days
PA9159 of 20 μg is delivered intranasally through a metered-dose mechanical spray pump, once daily in the morning for 14 days.
PA9159 nasal spray solution, 40 μg once daily for 14 days
PA9159 of 40 μg is delivered intranasally through a metered-dose mechanical spray pump, once daily in the morning for 14 days.
Placebo nasal spray solution without PA9159, once daily for 14 days
Placebo nasal spray solution is delivered intranasally through a metered-dose mechanical spray pump, once daily in the morning for 14 days.
The First Affiliated Hospital of Bengbu Medical College, Bengbu
The Second Hospital of Anhui Medical University, Hefei
Beijing Shijitan Hospital, Beijing
Beijing TongRen Hospital, Beijing
Dongfang Hospital Beijing University of Chinese Medicine, Beijing
Renmin Hospital of Wuhan University, Wuhan
Northern Jiangsu People's Hospital, Yangzhou
The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun
Tonghua Central Hospital, Tonghua
Yanbian University Hospital(Yanbian Hospital), Yanji
The Affiliated Hospital of Qingdao University, Qingdao
Yantai Yuhuangding Hospital, Yantai
Zibo Central Hospital, Zibo
First Hospital of Shanxi Medical University, Taiyuan
Second Hospital of Shanxi Medical University, Taiyuan
Tianjin People's Hospital, Tianjin
Zhejiang Provincial People's Hospital, Hangzhou
Lead Sponsor
Anhui Palo Alto Pharmaceuticals, Inc.
INDUSTRY